C4 Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $430.8M
Liabilities Breakdown FY2022
Total Liabilities: $141.6M
Asset Breakdown
Total Assets: $430.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $29.8M | 6.9% |
| Accounts Receivable | $1.5M | 0.3% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $7.4M | 1.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $392.2M | 91.0% |
Liabilities Breakdown
Total Liabilities: $141.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.2M | 0.8% |
| Long-Term Debt | $9.2M | 6.5% |
| Other Liabilities | $131.2M | 92.7% |